[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-366647-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-366647-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","mien1-promoter-deletion-leads-to-impaired-migration-and-invasion-potential-via-actin-cytoskeleton-rearrangement-in-colorectal-cancer","MIEN1 promoter deletion leads to impaired migration and invasion potential via actin cytoskeleton rearrangement in colorectal cancer","","Colorectal cancer (CRC) causes high cancer-associated mortality, and metastatic progression limits effective treatment. This study probes how deletion of the MIEN1 promoter alters CRC cell behavior by generating a CRISPR-Cas9 promoter knockout in HT29 cells. Functional assays and RNA sequencing reveal changes in actin cytoskeleton remodeling that correspond to reduced migration and invasion potential. Key actin-restructuring regulators, including pFAK-Y397 and pCofilin-S3, show distinct localization differences, indicating MIEN1-driven signaling control. Targeting MIEN1 may therefore support therapeutic strategies against CRC metastasis.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/mien1-promoter-deletion-leads-to-impaired-migration-and-invasion-potential-via-actin-cytoskeleton-rearrangement-in-colorectal-cancer/366647/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/mien1-promoter-deletion-leads-to-impaired-migration-and-invasion-potential-via-actin-cytoskeleton-rearrangement-in-colorectal-cancer/366647.png","ImageObject",300,407,{"name":42,"@type":43},"Bulrr","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-28","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What question does the study address about MIEN1 in colorectal cancer?","Question",{"text":63,"@type":64},"The study investigates how MIEN1 promoter deletion affects CRC progression by evaluating changes in migration and invasion potential and the underlying actin cytoskeleton-related mechanisms.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How was MIEN1 in CRC cells experimentally disrupted?",{"text":68,"@type":64},"Researchers used CRISPR-Cas9 to knock out the MIEN1 promoter region in the HT29 colorectal cancer cell line, creating a stable MIEN1 knockout line.",{"name":70,"@type":61,"acceptedAnswer":71},"What major mechanism links MIEN1 deletion to reduced migration and invasion?",{"text":72,"@type":64},"RNA sequencing and signaling analyses indicate that MIEN1 deletion disrupts actin cytoskeleton rearrangement, with altered localization of key actin remodeling proteins such as pFAK-Y397 and pCofilin-S3.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},366647,1790196704,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},5909892115043,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nMIEN1 promoter deletion leads to impaired migration and invasion potential via actin cytoskeleton rearrangement in colorectal cancer  \nPayal Ranade1, RuchaTrivedi1, Diana Carolina Sierra-Díaz2, Paul Laissue3 &  \nJamboor K. Vishwanatha1􀀍  \nColorectal cancer (CRC) is a leading cause of cancer-associated mortality worldwide. Although early-stage CRC is responsive to surgical resection, advanced metastatic disease poses formidable treatment obstacles, triggering an alarming decline in the survival rates of patients. Hence, studying the mechanisms underlying CRC progression and identifying novel therapeutic targets are critical for early diagnosis and treatment. The migration and invasion enhancer 1 (MIEN1) protein plays a pivotal role in tumor invasion and migration across various cancer types. InCRC, the predominant upregulation of MIEN1 in cancerous tissues is closely associated with invasive behavior; however, the precise mechanism driving the metastasis remains unexplored. In this study, we investigate the role of MIEN1 inCRC by generating a CRISPR-Cas9 mediated promoter knockout in HT29 CRC cell-line.  \nThe effects of MIEN1 deletion on critical biological processes and molecular pathways, including cell adhesion, migration, and invasion, were investigated using functional assays. RNA sequencing analysis indicated alterations in actin cytoskeleton rearrangement, ultimately manifesting as differences in cellular migration and invasion potential. Signaling molecules essential for actin remodeling, such as phosphorylated FAK (pFAK-Y397) and phosphorylated cofilin (pCofilin-S3), exhibited distinct differences in their cellular localization, implicating the role of MIEN1 in modulating these key proteins. Our findings emphasize the involvement of MIEN1in diverse signaling pathways responsible for CRC migration, with its deletion leading to the disruption of several biological processes, particularly actin cytoskeleton rearrangement, which is crucial for metastasis. Therefore, targeting MIEN1 may be an effective therapeutic strategy against CRC.  \nColorectal cancer (CRC) is the third most common cancer diagnosed globally and is one of the leading causes of cancer-associated mortality. Its progression is classified into four stages, with stages 3 and 4 being marked by an increased rate of malignancy1,2. If the cancer is diagnosed in the early stages, the tumor can be removed surgically; however, as the tumor gains metastatic ability, the overall survival rate of patients decreases drastically. Therefore, understanding the molecular mechanisms underlying CRC progression, which ultimately leads to metastasis, is crucial for developing effective therapeutic strategies.  \nMetastasis begins with the migration and invasion of cancer cells from the original tumor site to a distant organ. This process involves complex interactions between the signaling pathways and various proteins. Migration and invasion enhancer 1 (MIEN1) is an important protein involved in this process. Previously the protein was referred to by other names, such as C17orf37 and C35 . The gene for this protein is located on chromosome 17q12 positioned between ERBB2 oncogene and GRB7 in a tail-to-tail orientation, adjacent to the ERBB2/HER2 oncogene. It encodes a 112-amino acid protein of 15kD. Unlike many oncogenes driven by gene amplification, MIEN1 overexpression appears to be primarily regulated at the transcriptional level, including epigenetic changes such as promoter hypomethylation. The MIEN1 protein is overexpressed across various cancer types, significantly augmenting invasive and migratory phenotypes in breast, prostate, oral, and non–small cell lung cancers3–5, but has no detectable expression in normal or noncancerous adjacent tissues.  \n1Department of Microbiology, Immunology and Genetics, University of North Texas Health Science Center, Fort Worth, TX, USA. 2Center for Research in ","cbCaigvaJ0t4V8ak","https://ap.wps.com/l/cbCaigvaJ0t4V8ak","pdf",3708128,11,"English","# Introduction\n## Background on MIEN1 and CRC metastasis\n# Methods\n## CRISPR-Cas9 promoter knockout in HT29 cells\n## Functional assays and RNA sequencing\n## Analysis of actin cytoskeleton dynamics\n# Results\n## MIEN1 promoter ablation and ERBB2 amplicon status\n## Deletion confirmation and downstream phenotypic effects","[{\"question\":\"What question does the study address about MIEN1 in colorectal cancer?\",\"answer\":\"The study investigates how MIEN1 promoter deletion affects CRC progression by evaluating changes in migration and invasion potential and the underlying actin cytoskeleton-related mechanisms.\"},{\"question\":\"How was MIEN1 in CRC cells experimentally disrupted?\",\"answer\":\"Researchers used CRISPR-Cas9 to knock out the MIEN1 promoter region in the HT29 colorectal cancer cell line, creating a stable MIEN1 knockout line.\"},{\"question\":\"What major mechanism links MIEN1 deletion to reduced migration and invasion?\",\"answer\":\"RNA sequencing and signaling analyses indicate that MIEN1 deletion disrupts actin cytoskeleton rearrangement, with altered localization of key actin remodeling proteins such as pFAK-Y397 and pCofilin-S3.\"}]","MIEN1 promoter deletion leads to impaired migration and invasion potential via actin cytoskeleton rearrangement in colorectal cancer | PDF",1790166561,28,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bd71177cf0f5dfbc0d08b1682c6e4bad.webp",983,1291,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7123d1b62a8e1394a9aaf5a68f62f1ae.webp",982,1290,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d66d301a338b36cc2522223e296fa4a4.webp",981,1289,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bd925a9ad93864af8ceb10dbd598ed4b.webp",980,1287]